ABUS CapEx to Revenue
Arbutus Biopharma Corp · CapEx to Revenue
ABUS CapEx to Revenue
Current (TTM)0.00%retrieved
ABUS CapEx/Revenue (262.61% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
ABUS capex to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 0% | |
| 2.9493% | |
| 5.5565% | |
| 1.3122% | |
| 7.3626% | |
| 3.3121% | |
| 9.7987% | |
| 19.2881% | |
| 67.8879% | |
| 266.4% | |
| 9.1947% | |
| 7.04% | |
| 4.6889% | |
| 0.1051% | |
| 0.3585% | |
| 3.8912% | |
| 11.7789% | |
| 10.0256% | |
| 8.5657% | |
| 0.6974% | |
| 0.3387% | |
| 58.7443% | |
| 28.8323% | |
| 38.4604% | |
| 27.2194% | |
| 11.5187% | |
| 26.362% | |
| 262.6088% |